Article ; Online: Pancreatic cancer patients with germline BRCA mutations can benefit from olaparib treatment.
2022 Volume 9, Issue 4, Page(s) 2154–2156
Language | English |
---|---|
Publishing date | 2022-01-15 |
Publishing country | China |
Document type | Editorial ; Comment |
ZDB-ID | 2901601-0 |
ISSN | 2219-6803 ; 2218-676X |
ISSN (online) | 2219-6803 |
ISSN | 2218-676X |
DOI | 10.21037/tcr.2020.03.07 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.